Redirecting Chemotherapeutics to the Endoplasmic Reticulum Increases Tumor Immunogenicity and Potentiates Anti‐PD‐L1 Therapy
Author:
Affiliation:
1. Key laboratory of Drug Targeting and Drug Delivery System (Ministry of Education) West China School of Pharmacy Sichuan University No. 17, Block 3, South Renmin Road Chengdu 610041 P. R. China
Funder
Higher Education Discipline Innovation Project
Publisher
Wiley
Subject
Biomaterials,Biotechnology,General Materials Science,General Chemistry
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/smll.202104591
Reference49 articles.
1. Endoplasmic reticulum stress signals in the tumour and its microenvironment
2. Targeting the endoplasmic reticulum-stress response as an anticancer strategy
3. Endoplasmic reticulum stress regulates tumor growth and anti-tumor immunity: a promising opportunity for cancer immunotherapy
4. Role of Endoplasmic Reticulum Stress in the Anticancer Activity of Natural Compounds
5. Restoration and Enhancement of Immunogenic Cell Death of Cisplatin by Coadministration with Digoxin and Conjugation to HPMA Copolymer
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Advanced strategies for combinational immunotherapy of cancer based on polymeric nanomedicines;BMEMat;2024-01-12
2. Recent progress, perspectives, and issues of engineered PD-L1 regulation nano-system to better cure tumor: A review;International Journal of Biological Macromolecules;2024-01
3. Leveraging efferocytosis blockade for improved cancer chemo-immunotherapy through synchronized release of doxorubicin and BMS777607 confined within tailored mesoporous silica nanoparticles;Nano Today;2023-12
4. Modulation of Autophagy Direction to Enhance Antitumor Effect of Endoplasmic‐Reticulum‐Targeted Therapy: Left or Right?;Advanced Science;2023-06-08
5. Paraptosis Inducer to Effectively Trigger Immunogenic Cell Death for Metastatic Tumor Immunotherapy with IDO Inhibition;ACS Nano;2023-05-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3